2025 biotech outlook: Small-cap innovators tackling chronic and rare diseases

In the New Year, many small-cap biotech companies will be advancing promising clinical trials with innovative therapies aimed at addressing significant unmet medical needs. Key trials include those focused on cancer immunotherapies, treatments for neurological conditions like multiple sclerosis and Alzheimer's, as well as novel approaches to metabolic diseases and chronic pain. Here are the top trials to keep an eye on in 2025.  Candel Therapeutics Candel Therapeutics Inc (NASDAQ:CADL), which is advancing i ...